Adicet Bio, Inc. 007002108 6/11/2025 To approve, on a non-binding advisory basis, the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 DID NOT VOTE 0 NONE Altimmune Inc 02155H200 9/26/2024 An advisory vote on the compensation of the Company’s named executive officers as disclosed in the attached Proxy Statement SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 DID NOT VOTE 0 NONE Arrowhead Pharmaceuticals, Inc. 04280A100 3/12/2025 To conduct an advisory (non-binding) vote to approve executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 DID NOT VOTE 0 NONE Arrowhead Pharmaceuticals, Inc. 04280A100 3/12/2025 To conduct an advisory (non-binding) vote on the frequency of future advisory votes to approve executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 DID NOT VOTE 0 NONE Fate Therapeutics, Inc. 31189P102 5/29/2025 To conduct a non-binding advisory vote to approve the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 3379064 0 FOR 0 FOR Fate Therapeutics, Inc. 31189P102 5/29/2025 To conduct an advisory (non-binding) vote on the frequency of future advisory votes to approve executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 3379064 0 FOR 0 FOR Lyell Immunopharma Inc. 55083R104 5/15/2025 To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in this Proxy Statement SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 DID NOT VOTE 0 NONE Marker Therapeutics, Inc. 57055L206 6/6/2025 To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in this proxy statement SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 DID NOT VOTE 0 NONE Nano-X Imaging Ltd. M70700105 12/10/2024 To approve the equity-based compensation terms of the non-executive directors who shall serve in such capacity immediately following the Meeting SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 DID NOT VOTE 0 NONE Procept BioRobotics Corporation 74276L105 6/10/2025 To approve, on a non-binding advisory basis, the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 DID NOT VOTE 0 NONE Protagonist Therapeutics Inc 74366E102 6/20/2025 To approve, on a non-binding, advisory basis, the compensaon of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 2449183 0 FOR 0 FOR Senseonics Holdings, Inc. 81727U105 5/21/2025 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying this Notice SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 DID NOT VOTE 0 NONE Standard Biotools, Inc. 34385P108 6/18/2025 To approve, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 DID NOT VOTE 0 NONE Xencor, Inc. 98401F105 6/12/2025 To approve, on an advisory (non-binding) basis, the compensation of the Company’s named executive officers, as disclosed in the accompanying Proxy Statement SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 DID NOT VOTE 0 NONE